Related Events

ALLEGAN — Perrigo Co. reported first quarter 2009 revenue of $480 million, an increase of $97 million over the first quarter of last year. Net income for the quarter was $37.9 million, or 40 cents per share, compared with $34 million, or 36 cents per share in the year ago quarter.

“Fiscal 2009 is off to the strong start we had anticipated,” said Chairman and CEO Joseph C. Papa. “In the first quarter we achieved both record sales and record earnings, with our new products contributing $71 million to top line growth.”

In the first quarter Perrigo’s over-the-counter category grew nearly 4 percent and store brands grew nearly 13 percent over the year-ago quarter. In the prescription pharmaceutical segment, net sales were down from $35 million a year ago to $33.2 million at quarter’s end. In the company’s Active Pharmaceutical Ingredients segment net sales dipped from $38.8 million in the prior year’s first quarter to $34.2 million. Perrigo’s Israel Consumer Products and Israel Pharmaceutical and Diagnostic Products segments posted $46.6 million in the just passed quarter, up from $40.7 million a year ago.

Restricted Content

About GRBJ

Since 1983, the Grand Rapids Business Journal has been West Michigan's primary and most-trusted source of local business news. The weekly print edition of the Business Journal, a must-read for the area’s top decision-makers, is known as the business newspaper of metro Grand Rapids, Holland, Muskegon and all of West Michigan.

grbj.com provides the same trusted and objective business reporting that the Business Journal is known for -- plus real-time original content, timely enewsletters/alerts, exclusive blogs and more. Business Journal subscribers receive the weekly print edition, including bonus publications like the annual Book of Lists, and also complete access to all content on grbj.com.

The Grand Rapids Business Journal is published by Gemini Publications.